엔베노 메디컬 (NVNO) 주가

엔베노 메디컬(NVNO)는 NAS에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $8.98 (+2.22%), 시가총액 $6.55M, 52주 범위 $0.31 ~ $13.00.

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories.

핵심 지표

• 현재가: $8.98 (+2.22%)
• 시가총액: $6.55M
• 52주 최저~최고: $0.31 ~ $13.00
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NAS

엔베노 메디컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

엔베노 메디컬 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 적극 매수 (5.0 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.24
• 순이익률: 0.00%
• 영업이익률: 0.00%

자주 묻는 질문